Anondita Medicare IPO Details





Here is a detailed overview of the Anondita Medicare IPO for 2025:

Company Overview

Anondita Medicare Limited, incorporated in 1990, is a manufacturer and marketer of sexual wellness products. Its flagship brand, “COBRA,” is a well-recognized condom brand in India. The company operates a large-scale manufacturing facility with an installed capacity of 562 million condoms annually. It emphasizes quality and safety and caters to both the Indian domestic market and international exports.


IPO Key Details

DetailInformation
IPO Opening DateAugust 22, 2025
IPO Closing DateAugust 26, 2025
Allotment DateAugust 28, 2025
Refund Initiation DateAugust 29, 2025
Share Credit to DematAugust 29, 2025
Listing DateSeptember 1, 2025
Exchange ListingNSE (SME Platform)
Face Value₹10 per share
Price Band₹137 to ₹145 per share
Minimum Lot Size1000 shares
Minimum Retail Investment2 lots (2000 shares), approx ₹2,74,000
IPO Size₹69.50 Crores
Number of Shares on Offer47,93,000 equity shares (fresh issue only)
Type of Issue100% Fresh Issue (no Offer For Sale)
RegistrarMaashitla Securities Private Limited
Book Running Lead ManagerNarnolia Financial Services Limited
Market MakerMansi Share & Stock Broking Pvt Ltd

Objectives of the IPO Capital

  • To meet general corporate purposes.

  • To fund working capital requirements.

  • To finance capital expenditure, including equipment purchase.


Investment and Application Details

  • Retail investors must apply for a minimum of 2 lots (2000 shares), with an investment around ₹2,74,000.

  • High Net Worth Individuals (HNI) need to apply for at least 3 lots (3000 shares) requiring an investment of approximately ₹4,35,000.

  • The IPO is being issued through the book-building method.

  • Investors can apply through ASBA (Application Supported by Blocked Amount) or UPI-based methods via banks or registered brokers.


Market and Valuation Insights

  • Grey Market Premium (GMP) around ₹65 as of August 22, 2025, suggesting an estimated listing price of ₹210 per share.

  • This translates to an estimated listing gain of about 44.83%.

  • The issue size is ₹69.5 crore entirely through fresh equity issue, with no shares being sold by current promoters or investors.


Company Strength and Business Model

  • Leading player in the condom manufacturing segment under the “COBRA” brand.

  • Strong manufacturing capability with modern quality control systems.

  • Expanding distribution across India and growing export markets.

  • Committed workforce and certifications to comply with international quality standards.

  • Positioned in the healthcare and personal care sector, with growing demand for sexual wellness products.


Anchor Investors

Five anchor investors have been allotted shares before the public issue, including Vikasa India EIF, Sageone - Flagship, Cognizant Capital Dynamic, Minerva Emerging Opportunities, and Pine OAK Global.


IPO Timeline Summary

EventDate
IPO OpenAugust 22, 2025
IPO CloseAugust 26, 2025
Allotment FinalizationAugust 28, 2025
Refund InitiationAugust 29, 2025
Share Credit to DematAugust 29, 2025
Listing on NSE SMESeptember 1, 2025

Contact and Support

  • Registrar: Maashitla Securities Private Limited (for allotment queries and refunds)

  • Lead Manager: Narnolia Financial Services Limited (handling underwriting and IPO processes)

  • Market Maker: Mansi Share & Stock Broking Pvt. Ltd.


This comprehensive outline of the Anondita Medicare IPO covers its background, issue size, subscription details, objectives, timeline, and market expectations. Investors should consider the IPO price band, the lot size investment requirements, and the business fundamentals before applying. The issue is poised to list on September 1, 2025, on NSE SME, with an anticipated strong market debut based on GMP and investor interest



Follow Me

























Comments

Popular posts from this blog

Where is find client id in hdfc securities

Tata Capital IPO Date, Price, Size, ROE, Dividend Policy and How to apply

Reliance Jio Infocomm IPO 2025